Latest News for: iqv

Edit

Q3 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

The Call 07 Nov 2025
IQV) and its peers ... Weakest Q3. IQVIA (NYSE. IQV) ... IQV) provides clinical research services, data analytics, and technology solutions to help pharmaceutical companies develop and market medications more effectively ... Best Q3. Medpace (NASDAQ. MEDP) ... CRL) ... .
Edit

Why IQVIA (IQV) Shares Are Trading Lower Today

The Call 03 Nov 2025
What Happened?. Shares of clinical research company IQVIA (NYSE. IQV) fell 2.5% in the afternoon session after TD Cowen downgraded its rating on the stock from Buy to Hold ... P.S ... Today, the next Gorilla is emerging in AI-powered enterprise software ... .
Edit

IQVIA (NYSE:IQV) Beats Q3 Sales Expectations

The Call 28 Oct 2025
IQV) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 5.2% year on year to $4.1 billion ... IQVIA (IQV) Q3 CY2025 Highlights. ... IQV) provides clinical research services, data ...
Edit

IQVIA (IQV) Reports Earnings Tomorrow: What To Expect

The Call 27 Oct 2025
Clinical research company IQVIA (NYSE. IQV) will be reporting earnings this Tuesday morning. Here’s what investors should know. IQVIA beat analysts’ revenue expectations by 1.2% last quarter, reporting revenues of $4.02 billion, up 5.3% year on year ... .
Edit

Why IQVIA (IQV) Stock Is Trading Up Today

The Call 20 Oct 2025
What Happened?. Shares of clinical research company IQVIA (NYSE. IQV) jumped 3.6% in the afternoon session after Bank of America raised its price target on the company's shares to $230 from $215 ... More News. View More ... Via MarketBeat. Tickers CTAS FAST GEN.
Edit

ILMN Stock vs. IQV Stock

Forbes 26 Sep 2025
IQVIA (NYSE. IQV) presents stronger revenue growth during critical periods, enhanced profitability, and a relatively lower valuation compared to Illumina (ILMN)... .
  • 1

Article Search

tools
×
×
×
×